Apple Commits Over $30 Billion to U.S. Manufacturing in Major Broadcom Deal
The largest investment under Apple’s American Manufacturing Program.
/ 220 items
#andre↓
Wall Street Boosts Compass Pathways as COMP360 Durability Data Strengthens Path to 2027 Approval
Positive six-month COMP360 results trigger analyst upgrades and higher price targets for Compass Pathways. Strong durability data clears path to potential 2027 FDA approval in treatment-resistant depression.
William Blair Initiates Outperform Coverage on Zura Bio, Citing Strong Potential for Tibulizumab
William Blair cites strong upside potential for lead candidate tibulizumab in hidradenitis suppurativa and systemic sclerosis.
Chemomab Merges with Scipher Medicine to Advance AI-Powered Precision Treatment for Rheumatoid Arthritis
Chemomab and Scipher Medicine announce merger to develop nebokitug, a first-in-class anti-CCL24 antibody, in an AI-driven Phase 2 trial for rheumatoid arthritis. $30M new funding secured.
Chinese Tech Surge: Alibaba Leads Hang Seng Tech Rally on Accelerating Cloud Growth
Strong Cloud revenue outlook and narrower Taobao losses drove the surge, lifting the Hang Seng Tech Index 5%.
Barclays Initiates Cautious Coverage on PayPal with $42 Target Amid Growth Concerns
Despite the bearish call, analyst consensus sits near $53 with a Hold rating.